An update of molecular pathogenesis and diagnosis of myeloproliferative disorders in the JAK2 era.
Zhang
Su-jiang
SJ
Department of Hematology, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.
Li
Jian-yong
JY
D006801:Humans; D053614:Janus Kinase 2 / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000502:physiology; D009196:Myeloproliferative Disorders / Q000175:diagnosis* / Q000235:genetics*; D017354:Point Mutation; D011087:Polycythemia Vera / Q000235:genetics; D055728:Primary Myelofibrosis / Q000235:genetics; D013921:Thrombocytopenia / Q000235:genetics
D053614:Janus Kinase 2